A first-of-a-kind therapy that inhibits a population of T cells proved active and safe in a phase 3 trial for moderate to severe atopic dermatitis, introducing a novel mechanism to treat ...
Eczema is an umbrella term for a group of conditions that result in skin irritation and inflammation. The most common form of ...
A new survey commissioned by Leo Pharma confirms there’s plenty of room in the market for its chronic hand eczema treatment ...
Patients with atopic dermatitis (AD) who achieve completely clear skin with tapinarof (Vtama) cream maintain low dise ...
Half of patients who used delgocitinib cream for chronic hand eczema had a profound response, and a third who stopped ...
Stress is a nasty cycle: Feeling stressed can affect several skin and hair conditions, and living with those conditions can make you feel even more stressed.
After scoring a long-awaited FDA approval last fall, Eli Lilly has launched a consumer-facing campaign to get the word out ...
A break from treatment with Vtama won’t lead to worsening of patients’ atopic dermatitis, finds a new analysis of an ...
NIH researchers define diagnostic criteria for topical steroid withdrawal (TSW), distinguishing it from eczema.
Clinical trial results found that a majority of patients with atopic dermatitis who were treated with Ebgylss achieved ...
Once-daily roflumilast cream 0.05 percent is safe and effective for atopic dermatitis (AD) in patients ages 2 to 5 ye ...
Guttman-Yassky received research support, consulting, or lecture fees on atopic dermatitis from Regeneron, Sanofi, Pfizer, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback